In addition, BACH1 also functions as a tumor suppressor and controls survival of AML cells by regulating HO-1 expression [43], suggesting that functional upregulation of BACH1 is an alternative therapeutic strategy for antileukemic therapy. Here, BACH1 is linked to neoplasm.